GeoVax Labs, Inc. raises $3.0M Private Placement (United States, May 2026)
Find the investors funding Health Private Placement rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules - TradingView
GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on developing vaccines and immunotherapies for high-consequence infectious diseases and solid tumor cancers. The company is notable for its expedited regulatory pathway for its GEO-MVA vaccine targeting mpox and smallpox, with plans for a pivotal Phase 3 clinical trial in 2026.
GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules TradingView
| Oct 08, 2026 | Natron Energy | $10.2M | — | United States |
| Oct 08, 2026 | Hone | $60.0M | Seed | United States |
| Oct 08, 2026 | Arena | $200.0M | Series B | United States |
| Oct 08, 2026 | Quaise Energy | $25.0M | Grant | United States |
21,967 investors back startups in United States
You just read who funded GeoVax Labs, Inc.. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.